Status:
RECRUITING
Towards Improved Diagnostics for Suspected Platelet Function Disorders
Lead Sponsor:
Region Stockholm
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Platelet Function Disorder
Platelet Disorder
Eligibility:
All Genders
12+ years
Brief Summary
This study aims to improve platelet function testing during bleeding investigations. To this end, the study will evaluate the diagnostic accuracy of novel platelet function tests in patients with conf...
Eligibility Criteria
Inclusion
- Inclusion Criteria, known defects:
- Known platelet function disorder under follow-up at Karolinska University Hospital (genetic or functional assay)
- High likelihood of platelet function disorder (aberrant screening test with inheritance)
- Family investigation for platelet disorder
- Exclusion Criteria, known defects::
- Antiplatelet or anticoagulant drugs
- vWF:GPIb below 0.40 IU/mL
- Hematocrit below 0.35 or above 0.50
- Other coagulation disorder
- Inclusion Criteria, suspected platelet function disorder:
- Bleeding investigation at Karolinska University Hospital
- Exclusion Criteria, suspected platelet function disorder::
- Antiplatelet or anticoagulant drugs
- vWF:GPIb below 0.40 IU/mL
- Hematocrit below 0.35 or above 0.50
- Other coagulation disorder
Exclusion
Key Trial Info
Start Date :
September 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05985668
Start Date
September 5 2023
End Date
December 31 2026
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden